View of The impact of polypharmacy on adherence to pharmacotherapy for coronary heart disease with comorbid conditions: insights from the EUROASPIRE V observational study in Ukraine

Return to Article Details The impact of polypharmacy on adherence to pharmacotherapy for coronary heart disease with comorbid conditions: insights from the EUROASPIRE V observational study in Ukraine Download Download PDF